PositiveID Corporation Announces First Quarter 2012 Accomplishments: Positions Itself for $3 Billion BioWatch Contract and Advances the Development of Its Diabetes Management Products DELRAY BEACH, Fla., April 2, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes...

PositiveID Corporation Announces Initiation of Clinical Trial of Its Easy Check Non-Invasive Breath Glucose Detection Device DELRAY BEACH, Fla., Feb. 7, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that...

PositiveID Corporation to Launch Clinical Trial of Its Easy Check Non-Invasive Breath Glucose Detection Device This Month DELRAY BEACH, Fla., Jan. 5, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today it...

PositiveID Corporation Partners With Diabetes Research Institute at the University of Miami and Schneider Children's Medical Center of Israel to Support Development of PositiveID's Diabetes Management Products Diabetes Research Institute is a Recognized World Leader in Cure-Focused Diabetes Research Schneider Children's Medical Center of Israel is the Only Highly Specialized Care Hospital of...

PositiveID Corporation Successfully Completes Development of Its Continuous Glucose Sensor to Accurately Measure Glucose Levels in Human Blood DELRAY BEACH, Fla., July 14, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical...